Abstract
The in vitro activity of cefoxitin was compared with those of metronidazole and clindamycin against 322 strains of anaerobic bacteria collected from several hospitals during 1982 and tested by an agar dilution method. Metronidazole and cefoxitin inhibited at least 89% of strains tested, whereas clindamycin was less active.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Acar J. F., Goldstein F. W., Kitzis M. D., Eyquem M. T. Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period. J Antimicrob Chemother. 1981 Dec;8 (Suppl 500):9–16. doi: 10.1093/jac/8.suppl_d.9. [DOI] [PubMed] [Google Scholar]
- Arisawa M., Ohshima J., Ohsawa E., Maruyama H. B., Sekine Y., Mitsuhashi S. Bacteriological comparison of the activities of ceftriaxone, a new long-acting cephalosporin, with those of other new cephalosporins. Chem Pharm Bull (Tokyo) 1982 Jul;30(7):2544–2554. doi: 10.1248/cpb.30.2544. [DOI] [PubMed] [Google Scholar]
- Ayers L. W., Jones R. N., Barry A. L., Thornsberry C., Fuchs P. C., Gavan T. L., Gerlach E. H., Sommers H. M. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing. Antimicrob Agents Chemother. 1982 Nov;22(5):859–877. doi: 10.1128/aac.22.5.859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brogden R. N., Carmine A., Heel R. C., Morley P. A., Speight T. M., Avery G. S. Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy. Drugs. 1981 Dec;22(6):423–460. doi: 10.2165/00003495-198122060-00002. [DOI] [PubMed] [Google Scholar]
- Brown J. E., Del Bene V. E., Collins C. D. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance. Antimicrob Agents Chemother. 1981 Feb;19(2):248–252. doi: 10.1128/aac.19.2.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chow A. W., Patten V., Guze L. B. Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli. J Infect Dis. 1975 Feb;131(2):182–185. doi: 10.1093/infdis/131.2.182. [DOI] [PubMed] [Google Scholar]
- Cuchural G., Jacobus N., Gorbach S. L., Tally F. P. A survey of Bacteroides susceptibility in the United States. J Antimicrob Chemother. 1981 Dec;8 (Suppl 500):27–31. doi: 10.1093/jac/8.suppl_d.27. [DOI] [PubMed] [Google Scholar]
- Dhawan V. K., Bansal M. B., Thadepalli H. In vitro activity of pipecolic acid amide of clindamycin (U-57930E) on anaerobic bacteria compared with those of clindamycin, cefoxitin, and chloramphenicol. Antimicrob Agents Chemother. 1982 Aug;22(2):350–351. doi: 10.1128/aac.22.2.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dornbusch K., Nord C. E., Dahlbäck A. Antibiotic susceptibility of Clostridium species isolated from human infections. Scand J Infect Dis. 1975;7(2):127–134. doi: 10.3109/inf.1975.7.issue-2.09. [DOI] [PubMed] [Google Scholar]
- Dornbusch K., Nord C. E. In vitro effect of metronidazole and tinidazole on anaerobic bacteria. Med Microbiol Immunol. 1974;160(4):265–267. doi: 10.1007/BF02121441. [DOI] [PubMed] [Google Scholar]
- Drulak M. W., Chow A. W. Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria. Antimicrob Agents Chemother. 1981 Nov;20(5):683–685. doi: 10.1128/aac.20.5.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dublanchet A., Durieux R. Sensibilité comparée in vitro de quelques bactéries aérobies et anaérobies à trois dérivés des 5-nitro-imidazoles: le métronidazole, l'ornidazole et le tinidazole. Ann Microbiol (Paris) 1980 Jan-Feb;131(1):45–59. [PubMed] [Google Scholar]
- Goldstein E. J., Sutter V. L., Finegold S. M. Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538. Antimicrob Agents Chemother. 1978 Oct;14(4):609–613. doi: 10.1128/aac.14.4.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guin J. D., Huber D. S., Gielerak P. L. Antibiotic sensitivity of comedonal Propionibacterium acnes. Acta Derm Venereol. 1979;59(6):552–554. [PubMed] [Google Scholar]
- Hansen S. L. Variation in susceptibility patterns of species within the Bacteroides fragilis group. Antimicrob Agents Chemother. 1980 Apr;17(4):686–690. doi: 10.1128/aac.17.4.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hanslo D., King A., Shannon K., Warren C., Phillips I. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. J Antimicrob Chemother. 1981 Jun;7(6):607–617. doi: 10.1093/jac/7.6.607. [DOI] [PubMed] [Google Scholar]
- Jones R. N., Fuchs P. C., Barry A. L., Gavan T. L., Sommers H. M., Gerlach E. H. Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin. Antimicrob Agents Chemother. 1980 Apr;17(4):743–749. doi: 10.1128/aac.17.4.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kesado T., Watanabe K., Asahi Y., Isono M., Ueno K. Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics. Antimicrob Agents Chemother. 1982 Jun;21(6):1016–1022. doi: 10.1128/aac.21.6.1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marrie T. J., Haldane E. V., Swantee C. A., Kerr E. A. Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin. Antimicrob Agents Chemother. 1981 Jan;19(1):51–55. doi: 10.1128/aac.19.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rolfe R. D., Finegold S. M. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria. Antimicrob Agents Chemother. 1981 Nov;20(5):600–609. doi: 10.1128/aac.20.5.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ruckdeschel G. Activity in vitro of cefotetan against non-sporing anaerobes: a comparative study. J Antimicrob Chemother. 1983 Jan;11 (Suppl):117–124. doi: 10.1093/jac/11.suppl_a.117. [DOI] [PubMed] [Google Scholar]
- Sofianou D., Douboyas J., Papapanagiotou J., Paradelis A. G. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin. Methods Find Exp Clin Pharmacol. 1982;4(3):173–177. [PubMed] [Google Scholar]
- Sutter V. L., Barry A. L., Wilkins T. D., Zabransky R. J. Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother. 1979 Oct;16(4):495–502. doi: 10.1128/aac.16.4.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sutter V. L., Finegold S. M. Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother. 1976 Oct;10(4):736–752. doi: 10.1128/aac.10.4.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sutter V. L., Kwok Y. Y., Finegold S. M. Susceptibility of anaerobic bacteria to Sch 29482. J Antimicrob Chemother. 1982 Feb;9 (Suppl 100):171–174. doi: 10.1093/jac/9.suppl_c.171. [DOI] [PubMed] [Google Scholar]
- Tally F. P., Cuchural G. J., Jacobus N. V., Gorbach S. L., Aldridge K. E., Cleary T. J., Finegold S. M., Hill G. B., Iannini P. B., McCloskey R. V. Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother. 1983 Apr;23(4):536–540. doi: 10.1128/aac.23.4.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tally F. P., Jacobus N. V., Gorbach S. L. In vitro activity of N-formimidoyl thienamycin (MK0787). Antimicrob Agents Chemother. 1980 Oct;18(4):642–644. doi: 10.1128/aac.18.4.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tally F. P., Jacobus N. V. Susceptibility of anaerobic bacteria to imipenem. J Antimicrob Chemother. 1983 Dec;12 (Suppl 500):47–51. doi: 10.1093/jac/12.suppl_d.47. [DOI] [PubMed] [Google Scholar]
- Wilkins T. D., Thiel T. Resistance of some species of Clostridium to clindamycin. Antimicrob Agents Chemother. 1973 Jan;3(1):136–137. doi: 10.1128/aac.3.1.136. [DOI] [PMC free article] [PubMed] [Google Scholar]